Longevity Research Library · Educational Use Only

TB-500 Tissue Repair Research: Thymosin Beta-4 Mechanism & Data

Last reviewed 2026 · Source: peer-reviewed preclinical literature

What is TB-500?

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid protein found in virtually all human cells. Thymosin Beta-4 is one of the most abundant intracellular peptides in mammals and plays a central role in cell migration, differentiation, angiogenesis, and wound healing. TB-500 represents residues 17–23 of the full Tβ4 sequence — the active actin-binding domain.

Mechanism: Actin Sequestration and Cell Migration

Thymosin Beta-4's primary molecular function is sequestering G-actin monomers, preventing them from polymerising into F-actin filaments. This actin regulation is critical for cell motility — cells cannot migrate without dynamic actin remodelling. By modulating actin availability, TB-500 promotes directed cell migration toward wound sites and enhances the speed of tissue repair processes.

Angiogenesis Research

Preclinical studies have demonstrated that TB-500 promotes the formation of new blood vessels (angiogenesis) through upregulation of vascular endothelial growth factor (VEGF) and other angiogenic mediators. This is particularly significant in wound healing research, where impaired blood supply is a major barrier to tissue repair.

Cardiac and Myocardial Research

Animal models of myocardial infarction have shown that Thymosin Beta-4 administration post-injury promotes cardiac progenitor cell differentiation, reduces fibrosis, and improves cardiac function outcomes. This positions TB-500 as a research tool in cardiac regeneration science, complementary to standard myocardial repair studies.

Anti-Inflammatory Properties

TB-500 downregulates several pro-inflammatory cytokines including IL-1β, TNF-α, and NF-κB pathway activation. In animal models of joint inflammation and colitis, Tβ4 administration significantly reduced inflammatory markers and histological damage scores.

Research Dosing

ProtocolDoseFrequency
Loading phase5–7.5 mgTwice weekly, weeks 1–6
Maintenance2.5–5 mgOnce weekly, ongoing

TB-500 from QSC is available in 5 mg vials with full Janoshik COA. It is commonly researched in combination with BPC-157 for synergistic tissue repair effects.

Research-grade peptides with HPLC-verified COA
All compounds referenced in this guide are available at QSC Peptides (qscpeptide.com) — US domestic warehouse, fast shipping, batch-level certificates of analysis.

This page is for educational and research purposes only. All products sold by QSC are labelled for research use only and are not intended for human consumption. Nothing on this page constitutes medical advice.